47.73.Z - Retail sale of pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
96.02.Z - Individual service activities
96.04.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | 0,7 | 0,8 | 11,6 |
Gross profit (loss) | 0 | 0,6 | 0,6 | 5,3 |
EBITDA | 0 | 0,7 | 0,8 | 10,9 |
Short time liabilities | 2 | 2,2 | 2,4 | 7,6 |
Other operating costs | 0 | 0 | 0 | -5,9 |
Equity capital | 0 | 0,6 | 1,3 | 104,6 |
Operating profit (EBIT) | 0 | 0,7 | 0,8 | 10,8 |
Assets | 2 | 2,8 | 3,6 | 28,6 |
Net profit (loss) | 0 | 0,6 | 0,6 | 5,3 |
Cash | 0 | 0,1 | 0,6 | 769,6 |
Net income from sale | 0 | 11,1 | 12,5 | 12,2 |
Liabilities and provisions for liabilities | 2 | 2,2 | 2,4 | 7,6 |
Working assets | 2 | 1,3 | 2,1 | 59,9 |
Other income costs | 0 | 0,1 | 0,1 | -1,6 |
Depreciation | 0 | 0 | 0 | 19,1 |
% | % | % | p.p. | |
Profitability of capital | 0 | 99,3 | 51,1 | -48,2 |
Equity capital to total assets | 0,2 | 21,6 | 34,4 | 12,8 |
Gross profit margin | 5,5 | 5,1 | -0,4 | |
EBITDA Margin | 6,7 | 6,6 | -0,1 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 73 | 70 | -3 |
Current financial liquidity indicator | 1.0020283460617065 | 0.5992397665977478 | 0.8902987241744995 | 0,3 |
Net dept to EBITDA | 0.929069995880127 | 0.30314901471138 | -0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane